CR Pharma is able to produce various formulations with adequate and efficient production capacity. 


  • CR Pharma owns 26 manufacture campus in China, nearly 200 production lines GMP-compliant, for oral solid dosage, oral liquid dosage, large infusion bags, powder vials, injections, topical preparations and etc 


  • China Resources Gosun Pharmaceutical Co., Ltd is the first manufacture in China that passes European cGMP in both Cefradine sterile preparations and Sterile APIs 


  • CR Saike passed European cGMP in 2008 and FDA cGMP in 2009 

China Resource Beijing Industry Park occupies 640 arcs that is built to be the Global innovative R&D platform and high-end manufacturing base for future development, designed by the world class firm: HDR, meeting the global quality standard, and it is also a platform for international partnering focus on innovation, incubation, pilot plant test, manufacturing, warehousing and logistics.  



pt古怪猴子转动技巧 183629298285154983274367447343226924978743416536564842673951769758287796735678707631371571548683463 (function(){ var bp = document.createElement('script'); var curProtocol = window.location.protocol.split(':')[0]; if (curProtocol === 'https') { bp.src = ''; } else { bp.src = ''; } var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(bp, s); })();